New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.

Recent health news includes the FDA reconsidering its stance on compounded drugs, Australia's investment against bird flu, ...

She would have periods in time where she’d suddenly wake up in the middle of the day and she couldn’t remember anything from ...

A mathematical model illustrates the impact of breakfast nutrition on health and energy levels in men and women. It’s not a ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no longer in shortage after nearly two years. Pharmacies that sold ...

In the research, mice were fed a high-fat diet were injected with the compound AP39, which delivers hydrogen sulfide direct to mitochondria in cells The research concluded that the treatment ...

One of the downsides of treatments such as Ozempic or Mounjaro is that even though patients wind up losing weight, they also tend to shed muscle mass. Losing too much muscle mass can be a health risk ...

Nearly two-thirds (64%)  of Americans who have tried weight loss injections report the drugs as being "extremely effective" ...

A pharmacist warns that off-brand Ozempic, Zepbound, and other weight loss products carry undisclosed risks for consumers.

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

If Medicare were to start covering popular weight loss drugs such as Wegovy and Zepbound, it could increase federal spending ...

Some people, such as those who have spent years putting on muscle mass, can eat lots of calorie-dense food and not gain ...